USAU

9.05

-0.11%↓

USAU

9.05

-0.11%↓

USAU

9.05

-0.11%↓

USAU

9.05

-0.11%↓

USAU

9.05

-0.11%↓

Search

Ashland Global Holdings Inc

Uždarymo kaina

SektoriusPagrindinės medžiagos

57.74 -2.65

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

57.03

Max

59.09

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-181M

-165M

Pardavimai

-117M

405M

Pelnas, tenkantis vienai akcijai

0.28

Dividendų pajamingumas

2.73

Pelno marža

-40.741

Darbuotojai

3,200

EBITDA

-223M

-140M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+31.94% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

2.73%

2.80%

Kitas uždarbis

2025-04-29

Kitas dividendų mokėjimo data

2025-06-13

Kita Ex Dividend data

2025-05-30

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

2.8B

Ankstesnė atidarymo kaina

60.39

Ankstesnė uždarymo kaina

57.74

Naujienos nuotaikos

By Acuity

50%

50%

76 / 170 reitingas Basic materials

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bullish Evidence

Ashland Global Holdings Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-03-17 11:00; UTC

Įsigijimai, susijungimai, perėmimai

Ashland Completes Sale of Avoca Business to Mane

2025-01-28 22:05; UTC

Uždarbis

Ashland 1Q Adj EPS 28c >ASH

2025-01-28 22:04; UTC

Uždarbis

Ashland Backs FY25 Sales $1.9B-$2.05B >ASH

2025-01-28 22:04; UTC

Uždarbis

Ashland 1Q Sales $405M >ASH

2025-01-28 22:04; UTC

Uždarbis

Ashland 1Q Cont Ops Loss/Shr $3.51 >ASH

2025-01-28 22:03; UTC

Uždarbis

Ashland 1Q Loss/Shr $3.50 >ASH

2024-11-06 22:07; UTC

Uždarbis

Ashland 4Q EPS 39c >ASH

2024-11-06 22:07; UTC

Uždarbis

Ashland 4Q Sales $522M >ASH

2024-11-06 22:07; UTC

Uždarbis

Ashland Sees FY25 Sales $1.90B-$2.05B >ASH

2024-09-03 11:00; UTC

Įsigijimai, susijungimai, perėmimai

Ashland Completes Sale of Nutraceuticals Business to Affil of Turnspire Capital Partners >ASH

2024-08-06 21:04; UTC

Uždarbis

Ashland Sees FY Sales $2.1B >ASH

2024-08-06 21:03; UTC

Uždarbis

Ashland Sees 4Q Sales $530M-$540M >ASH

2024-08-06 21:03; UTC

Uždarbis

Ashland 3Q Adj EPS $1.49 >ASH

2024-08-06 21:02; UTC

Uždarbis

Ashland 3Q Sales $544M >ASH

2024-08-06 21:02; UTC

Uždarbis

Ashland 3Q Cont Ops EPS 60c >ASH

2024-08-06 21:02; UTC

Uždarbis

Ashland 3Q EPS 12c >ASH

2024-08-06 21:02; UTC

Uždarbis

Ashland Issues Outlook for 4Q and Full-Yr Fiscal 2024

2024-05-07 11:01; UTC

Įsigijimai, susijungimai, perėmimai

Ashland: Transaction Is Expected to Close in 3Q >ASH

2024-05-07 10:59; UTC

Įsigijimai, susijungimai, perėmimai

Ashland Signs Definitive Agreement to Sell Nutraceuticals Business to Turnspire Capital Partners >ASH

Akcijų palyginimas

Kainos pokytis

Ashland Global Holdings Inc Prognozė

Kainos tikslas

By TipRanks

31.94% į viršų

12 mėnesių prognozė

Vidutinis 77.86 USD  31.94%

Aukščiausias 93 USD

Žemiausias 68 USD

Remiantis 9 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Ashland Global Holdings Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

9 ratings

6

Pirkti

3

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

56.33 / 59.72Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bullish Evidence

Vidutinės trukmės periodas

Weak Bearish Evidence

Ilgalaikis periodas

Weak Bearish Evidence

Rinkos nuotaikos

By Acuity

76 / 170 reitingas Pagrindinės medžiagos

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Ashland Global Holdings Inc

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.